Project Optimus For Kids: US FDA Aims To Improve Dosage Optimization For Pediatric Cancer Drugs

 
• By Sue Sutter

Pediatric studies of promising cancer drugs can begin before the ideal dose is identified for adults, although some dose optimization work in children may be better left to the postmarket setting, advisory committee members said.  

Childhood cancer
Cancer drug studies in children do not have to wait until an optimized dose is identified in adults. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers